Business Description
Ono Pharmaceutical Co Ltd
ISIN : US6827361030
Share Class Description:
OPHLY: ADRTotal Employee Number:
4,287Description
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.97 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 0.9 | |||||
Interest Coverage | 26.06 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.87 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | -4.9 | |||||
3-Year EPS without NRI Growth Rate | -13.7 | |||||
3-Year FCF Growth Rate | -15.7 | |||||
3-Year Book Growth Rate | 6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -3.72 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.57 | |||||
9-Day RSI | 50.1 | |||||
14-Day RSI | 51.38 | |||||
3-1 Month Momentum % | -9.96 | |||||
12-1 Month Momentum % | 31.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.86 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 1.46 | |||||
Days Inventory | 174.28 | |||||
Days Sales Outstanding | 100.91 | |||||
Days Payable | 177.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.44 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 4.6 | |||||
Forward Dividend Yield % | 3.44 | |||||
5-Year Yield-on-Cost % | 6.17 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 5.73 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.52 | |||||
Operating Margin % | 17.88 | |||||
Net Margin % | 13.53 | |||||
EBITDA Margin % | 25.97 | |||||
FCF Margin % | 15.42 | |||||
OCF Margin % | 26.18 | |||||
ROE % | 8.61 | |||||
ROA % | 6.54 | |||||
ROIC % | 8.81 | |||||
3-Year ROIIC % | -26.75 | |||||
ROC (Joel Greenblatt) % | 41.31 | |||||
ROCE % | 10.43 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.82 | |||||
Forward PE Ratio | 15.82 | |||||
PE Ratio without NRI | 14.82 | |||||
Shiller PE Ratio | 14.82 | |||||
Price-to-Owner-Earnings | 12.44 | |||||
PEG Ratio | 13.47 | |||||
PS Ratio | 2.16 | |||||
PB Ratio | 1.32 | |||||
Price-to-Tangible-Book | 2.36 | |||||
Price-to-Free-Cash-Flow | 13.43 | |||||
Price-to-Operating-Cash-Flow | 8.2 | |||||
EV-to-EBIT | 9.71 | |||||
EV-to-Forward-EBIT | 7.61 | |||||
EV-to-EBITDA | 6.98 | |||||
EV-to-Forward-EBITDA | 6.79 | |||||
EV-to-Revenue | 1.82 | |||||
EV-to-Forward-Revenue | 2.41 | |||||
EV-to-FCF | 11.82 | |||||
Price-to-GF-Value | 1.04 | |||||
Price-to-Projected-FCF | 0.66 | |||||
Price-to-DCF (Earnings Based) | 0.76 | |||||
Price-to-DCF (FCF Based) | 0.68 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Graham-Number | 1.3 | |||||
| Price-to-Net-Current-Asset-Value | 5.26 | |||||
Earnings Yield (Greenblatt) % | 10.3 | |||||
FCF Yield % | 7.61 | |||||
Forward Rate of Return (Yacktman) % | 6.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:OPHLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ono Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,404.817 | ||
| EPS (TTM) ($) | 0.33 | ||
| Beta | -0.1504 | ||
| 3-Year Sharpe Ratio | -0.36 | ||
| 3-Year Sortino Ratio | -0.5 | ||
| Volatility % | 25.06 | ||
| 14-Day RSI | 51.38 | ||
| 14-Day ATR ($) | 0.094363 | ||
| 20-Day SMA ($) | 4.83385 | ||
| 12-1 Month Momentum % | 31.28 | ||
| 52-Week Range ($) | 3.52 - 5.75 | ||
| Shares Outstanding (Mil) | 1,409.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ono Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ono Pharmaceutical Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| USD 0.082241 Cash Dividend | 2026-03-31 | 5.28 (+0.38%) | ||
| USD 0.085905 Cash Dividend | 2025-09-30 | 3.81 (+1.17%) | ||
| USD 0.091386 Cash Dividend | 2025-03-31 | 3.64 (-2.28%) | ||
| USD 0.088729 Cash Dividend | 2024-09-30 | 4.43 (-1.01%) | ||
| 3:1 Stock Split | 2016-04-04 | 13.98 (+0.96%) | ||
| 5:1 Stock Split | 2014-05-29 | 5.29 (+0.13%) |
Show
Entries
Ono Pharmaceutical Co Ltd Frequently Asked Questions
What is Ono Pharmaceutical Co Ltd(OPHLY)'s stock price today?
The current price of OPHLY is $4.89. The 52 week high of OPHLY is $5.75 and 52 week low is $3.52.
When is next earnings date of Ono Pharmaceutical Co Ltd(OPHLY)?
The next earnings date of Ono Pharmaceutical Co Ltd(OPHLY) is .
Does Ono Pharmaceutical Co Ltd(OPHLY) pay dividends? If so, how much?
The Dividend Yield %  of Ono Pharmaceutical Co Ltd(OPHLY) is 3.44% (As of Today), Highest Dividend Payout Ratio of Ono Pharmaceutical Co Ltd(OPHLY) was 0.75. The lowest was 0.3. And the median was 0.38. The  Forward Dividend Yield % of Ono Pharmaceutical Co Ltd(OPHLY) is 3.44%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:OPHLY
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals | 2024-04-30 | ||
| Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million | 2023-12-01 |
Articles on Ono Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers